← Back to Search

Apple Watch for Pediatric Arrhythmia (PAWS Trial)

N/A
Waitlist Available
Led By Scott Ceresnak, MD
Research Sponsored by Stanford University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Pediatric patients age 6 - 21 years undergoing clinically indicated arrhythmia monitoring
Be younger than 65 years old
Must not have
Age < 6 years
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 6 months
Awards & highlights
No Placebo-Only Group

Summary

This trial tests if the Apple Watch ECG is accurate in measuring heart rate in kids, and if it can detect undiagnosed heart conditions.

Who is the study for?
This trial is for children and young adults aged 6 to 21 who are undergoing monitoring for heart rhythm problems. Participants must be able to wear an Apple Watch safely and use its features, including the trigger buttons.
What is being tested?
The study aims to test how accurately the Apple Watch can record ECG tracings and heart rate in kids. It also looks at whether using the watch longer term catches any arrhythmias that shorter clinical tests might miss.
What are the potential side effects?
Wearing an Apple Watch is generally safe but may include discomfort from wearing the device continuously or skin irritation. The study does not involve medication, so drug-related side effects are not expected.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am between 6 and 21 years old and need heart rhythm monitoring.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
I am under 6 years old.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 6 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 6 months for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Arrhythmia correlation
Heart rate correlation

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups
Experimental Treatment
Group I: Apple WatchExperimental Treatment1 Intervention
Participants will wear an Apple Watch for 6 months
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Apple Watch
2022
N/A
~550

Find a Location

Who is running the clinical trial?

Stanford UniversityLead Sponsor
2,468 Previous Clinical Trials
17,496,162 Total Patients Enrolled
Scott Ceresnak, MDPrincipal InvestigatorStanford University
~67 spots leftby Aug 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top